Noticias de GH_US

Noticias del mercado

Últimas noticias sobre GH_US — 236 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: GH_US ✕ 236 resultados
01/05/2026 GH_US — Stock Titan
Director at Guardant Health (GH) exercises 154 RSUs and holds 19,362 shares
30/04/2026 GH_US — MSN ES ← EN
MSN Dinero

MSN Money

30/04/2026 GH_US — GuruFocus ES ← EN
Historia del holding Guardant Health Inc (GH) de Lagoda Investment Management, L.P.

Lagoda Investment Management, L.P.'s Guardant Health Inc(GH) Holding History

30/04/2026 GH_US — BioSpace
Guardant Health Announces Multi-Year Strategic Collaboration with Nuvalent to Develop Companion Diagnostics and Support Potential Commercialization of Targeted Cancer Therapies Using the Guardant Infinity™ Platform
30/04/2026 GH_US — GuruFocus ES ← EN
INVESCO V.I. Historial de tenencias de Guardant Health Inc (GH) de Small Cap Equity Fund

INVESCO V.I. Small Cap Equity Fund's Guardant Health Inc(GH) Holding History

30/04/2026 GH_US — Investing.com South Africa ES ← EN
Guardant Health se asocia con Nuvalent en pruebas de diagnóstico Por Investing.com

Guardant Health partners with Nuvalent on diagnostic tests By Investing.com

30/04/2026 GH_US — MarketBeat ES ← EN
Delta Investment Management LLC compra acciones de 22,236 Guardant Health, Inc. $GH

Delta Investment Management LLC Buys Shares of 22,236 Guardant Health, Inc. $GH

30/04/2026 GH_US — MarketBeat ES ← EN
Guardant Health, Inc. Posición de $GH recortada por Jennison Associates LLC

Guardant Health, Inc. $GH Position Trimmed by Jennison Associates LLC

30/04/2026 GH_US — openPR.com ES ← EN
Mercado de diagnóstico de cáncer de mama metastásico mutado ESR1

ESR1 Mutated Metastatic Breast Cancer Diagnostics Market

30/04/2026 GH_US — Investing.com Australia ES ← EN
Guardant Health se asocia con Nuvalent en pruebas de diagnóstico Por Investing.com

Guardant Health partners with Nuvalent on diagnostic tests By Investing.com

30/04/2026 GH_US — Investing.com ES ← EN
Guardant Health se asocia con Nuvalent en pruebas de diagnóstico Por Investing.com

Guardant Health partners with Nuvalent on diagnostic tests By Investing.com

30/04/2026 GH_US — Investing.com UK ES ← EN
Guardant Health se asocia con Nuvalent en pruebas de diagnóstico Por Investing.com

Guardant Health partners with Nuvalent on diagnostic tests By Investing.com

30/04/2026 GH_US — Bitget ES ← EN
Guardant Health Inc. anuncia una asociación estratégica de varios años con la empresa biofarmacéutica Nuvalent

Guardant Health Inc. announces a multi-year strategic partnership with biopharmaceutical company Nuvalent

30/04/2026 GH_US — The Joplin Globe ES ← EN
Guardant Health anuncia una colaboración estratégica de varios años con Nuvalent para desarrollar diagnósticos complementarios y respaldar la posible comercialización de terapias dirigidas contra el cáncer utilizando la plataforma Guardant Infinity™

Guardant Health Announces Multi-Year Strategic Collaboration with Nuvalent to Develop Companion Diagnostics and Support Potential Commercialization of Targeted Cancer Therapies Using the Guardant Infinity™ Platform

30/04/2026 GH_US — FinancialContent
Guardant Health Announces Multi-Year Strategic Collaboration with Nuvalent to Develop Companion Diagnostics and Support Potential Commercialization of Targeted Cancer Therapies Using the Guardant Infinity™ Platform
30/04/2026 GH_US — MarketBeat ES ← EN
Guardant Health, Inc. (NASDAQ:GH) recibió una calificación promedio de "compra moderada" por parte de los analistas

Guardant Health, Inc. (NASDAQ:GH) Given Average Rating of "Moderate Buy" by Analysts

30/04/2026 GH_US — ChartMill
Guardant Health Announces Multi-Year Strategic Collaboration with Nuvalent to Develop Companion Diagnostics and Support Potential Commercialization of Targeted Cancer Therapies Using the Guardant Infinity™ Platform
30/04/2026 GH_US — Investing.com
Guardant Health partners with Nuvalent on diagnostic tests
30/04/2026 GH_US — Yahoo Finance
Guardant Health (GH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
30/04/2026 GH_US — Stock Titan
Vanguard holds 6.59M shares of Guardant Health (NYSE: GH) — 5.02% stake

Página 5 de 12

keyboard_arrow_up